Basics MIRUM PHARMACEUTICALS, INC. IPO Date: July 12, 2019 Sector: Healthcare Industry: Biotech Market Cap: $2.17B Activated in VL: True Average Daily Range Avg Daily Range: $0.59 | 2.60% Avg Daily Range (30 D): $0.66 | 1.54% Avg Daily Range (90 D): $0.82 | 1.82% Institutional Daily Volume Avg Daily Volume: .26M Avg Daily Volume (30 D): .3M Avg Daily Volume (90 D): .38M Trade Size Avg Trade Size (Sh.): 61 Avg Trade Size (Sh.) (30 D): 42 Avg Trade Size (Sh.) (90 D): 46 Institutional Trades Total Inst.Trades: 1,501 Avg Inst. Trade: $2.01M Avg Inst. Trade (30 D): $2.27M Avg Inst. Trade (90 D): $2.75M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.45M Avg Closing Trade (30 D): $2.77M Avg Closing Trade (90 D): $3.17M Avg Closing Volume: 79.87K         News Jun 18, 2024 @ 3:14 PM Mirum (MIRM) Soars on Interim Data From Liver Dise... Source: Zacks Equity Research Jun 18, 2024 @ 9:46 AM Mirum Pharmaceuticals (MIRM) Soars 27.3%: Is Furth... Source: Zacks Equity Research Jun 7, 2024 @ 3:30 PM Why Is Mirum Pharmaceuticals (MIRM) Down 3.4% Sinc... Source: Zacks Equity Research May 28, 2024 @ 2:02 PM Mirum's (MIRM) Livmarli Aids Sales but Overdepende... Source: Zacks Equity Research May 9, 2024 @ 3:46 PM Mirum's (MIRM) Q1 Earnings & Revenues Fall Shy of ... Source: Zacks Equity Research Financials   TTM Q4 2024 FY 2024 Basic EPS $-.3 $-.49 $-1.85 Diluted EPS $-.3 $-.49 $-1.85 Revenue $ 111.59M $ 99.41M $ 336.89M Gross Profit $ $ $ Net Income / Loss $ -14.68M $ -23.79M $ -87.94M Operating Income / Loss $ -15.18M $ -24.22M $ -87.61M Cost of Revenue $ $ $ Net Cash Flow $ -11.74M $ .91M $ -62.1M PE Ratio